Inhibikase Therapeutics Inc. (IKT)
NASDAQ · Healthcare
Inhibikase Therapeutics Inc. Total Assets 2020–2024
Inhibikase Therapeutics Inc. annual total assets history from 2020 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Inhibikase Therapeutics Inc. total assets as of December 31, 2024: 98.6M, a 579.69% increase year-over-year.
- Inhibikase Therapeutics Inc. total assets for 2024 were 98.6M, a 579.69% increase from 2023.
- Inhibikase Therapeutics Inc. total assets for 2023 were 14.5M, a 41.83% decrease from 2022.
- Inhibikase Therapeutics Inc. total assets for 2022 were 24.9M, a 41.28% decrease from 2021.
- Inhibikase Therapeutics Inc. total assets for 2021 were 42.5M.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inhibikase Therapeutics Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2024 | $99 |
| 2023 | $15 |
| 2022 | $25 |
| 2021 | $42 |
| 2020 | $15 |
Inhibikase Therapeutics Inc. Total Assets — FAQ
Inhibikase Therapeutics Inc. (IKT) total assets over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IKT's total assets history?
The chart and table above show Inhibikase Therapeutics Inc.'s total assets by year and by quarter, including the growth rate.